IP Library Granted Patent US 11,370,752
Granted Patent B2
US 11,370,752 · App. 16/482,981 · Granted Jun 28, 2022

Process for preparing cyclododecanone

Inventors: Luca Cameretti (Dortmund, DE); Jan Caßens (Datteln, DE); Ralf Meier (Dortmund, DE)
Assignee: Evonik Operations GmbH
C07D201/10C07C49/307
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,370,752
App. No.
16/482,981
Granted
Jun 28, 2022
Kind
B2
Abstract

The invention relates to a method for producing cyclododecanone (CDON). During the production, contaminated cyclododecane (CDAN) is produced. This can be separated from CDON by distillation (CDAN-containing fraction). The separation of CDAN and impurities such as 13-oxabicyclo [7.3.1]tridecane occurs by crystallizing out CDAN from the CDAN-containing fraction.

Claims (22)

1. A process for the purification of cyclododecane (CDAN) comprising the consecutive steps of:

a) reaction of 1,5,9-cyclododecatriene (CDT) to afford a mixture of cyclododecanol (CDOL) and CDON,

b) dehydrogenation of the CDOL to afford CDON, wherein a CDON-containing mixture which comprises cyclododecane (CDAN) is obtained,

c) distillation of the CDON-containing mixture to obtain a fraction comprising CDAN (CDAN-containing fraction) and a CDON-containing fraction, and

d) crystallizing-out CDAN from the CDAN-containing fraction by melt crystallization or solution crystallization; and

wherein the mixture of CDOL and CDON is obtained by the consecutive steps of

i) hydrogenation of CDT to afford CDAN and

ii) oxidation of CDAN to afford the mixture of CDOL and CDON; or

wherein the mixture of CDOL and CDON is obtained by the consecutive steps of

I) hydrogenation of CDT to afford cyclododecene (CDEN),

II) epoxidation of CDEN to afford cyclododecane epoxide (CDAN epoxide) and

III) rearrangement of CDAN epoxide to afford the mixture of CDOL and CDON.

2. The process according to claim 1 , wherein the CDAN-containing fraction contains impurities which comprise 13-oxabicyclo[8.2.1]tridecane, 13-oxabicyclo[7.3.1]tridecane, 2-undecanone or mixtures thereof.

3. The process according to claim 2 , wherein the impurity comprises 13-oxabicyclo[7.3.1]tridecane.

4. The process according to claim 1 , wherein the crystallized-out CDAN (step d) is oxidized to afford a mixture of CDOL and CDON.

5. The process according to claim 1 , wherein the crystallized-out CDAN (step d) is converted into cyclododecanone oxime with nitrosyl chloride.

6. The process according to claim 1 , wherein the CDON is removed from the CDON-containing fraction by distillation.

7. The process according to claim 1 , wherein the CDAN-containing fraction is distilled to remove low boilers before the crystallizing-out.

8. The process according to claim 1 , wherein the melt crystallization is selected from static crystallization, falling film crystallization or suspension crystallization.

9. The process for purifying cyclododecane (CDAN),

wherein the CDAN contains impurities selected from 13-oxabicyclo[8.2.1]tridecane, 13-oxabicyclo[7.3.1]tridecane, 2-undecanone or mixtures thereof,

wherein the CDAN is crystallized-out by crystallization selected from melt crystallization or solution crystallization.

Assignments (2)
CHANGE OF NAME Recorded Nov 26, 2019
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051136/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2019
From: CAMERETTI, LUCA; CASSENS, JAN; MEIER, RALF
To: EVONIK DEGUSSA GMBH
Reel/Frame 050344/0524 →
Priority Claims (1)
DE 102017000989.9 · Feb 3, 2017 · national
Continuity (1)
Related Publication 20190345101A1 · Nov 14, 2019